A Multi-center Noninterventional Study to Evaluate the Effectiveness of Neupro (Rotigotine Transdermal Patch) and Levodopa Combination Therapy in Patients With Parkinson's Disease (NEUPART)

Trial Profile

A Multi-center Noninterventional Study to Evaluate the Effectiveness of Neupro (Rotigotine Transdermal Patch) and Levodopa Combination Therapy in Patients With Parkinson's Disease (NEUPART)

Completed
Phase of Trial: Phase IV

Latest Information Update: 08 Jun 2017

At a glance

  • Drugs Rotigotine (Primary) ; Levodopa
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Acronyms NEUPART
  • Sponsors UCB
  • Most Recent Events

    • 08 Jun 2017 Primary endpoint has been met. (Change from Baseline to end of the Observational Period in Unified Parkinsons Disease Rating Scale Part II (UPDRS Part II) total score), according to results presented at the 21st International Congress of Parkinson's Disease and Movement Disorders.
    • 08 Jun 2017 Results presented at the 21st International Congress of Parkinson's Disease and Movement Disorders
    • 08 Jun 2016 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top